The FDA announced on June 17, 2014, that Hospira Inc. voluntarily recalled Marcaine (bupivacaine HCl) injection vials due to the presence of particulate matter. The recall affects 40,730 units distributed nationwide.
How to tell if you have it
- Brand: Hospira
- Product: Marcaine Injection Vials
- NDC: 0409-1560-29
- Lot #: 33-545-DD
- Expiration Date: 09/15
- Quantity: 40,730 vials
The hazard
The recall addresses confirmed customer complaints of discolored solution containing visible metal particles embedded in the glass vial and suspended in the solution. This particulate matter poses a potential health risk to patients.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (July 24, 2026) and GE Healthcare Omnipaque 300 mg/mL Injection Recall (March 24, 2026).